43
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Step-down therapy in well-controlled asthmatic patients using salmeterol xinafoate/fluticasone propionate combination therapy

, , , , &
Pages 65-70 | Published online: 18 Mar 2016

References

  • GreeningAPIndPWNorthfieldMShawGAdded salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen and Hanburys Limited UK Study GroupLancet199434489172192247913155
  • PauwelsRALöfdahlCGPostmaDSEffect of inhaled formoterol and budesonide on exacerbation of asthma: formoterol and corticosteroids establishing therapy (FACET) International Study GroupN Eng J Med19973372014051411
  • KramerJMBalancing the benefits and risks of inhaled long-acting beta-agonists the influence of valuesN Engl J Med2009360161592159519369665
  • NelsonHSWeissSTBleeckerERSMART Study GroupThe salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterolChest20061291152616424409
  • ChowdhuryBADal PanGThe FDA and safe use of long-acting beta-agonists in the treatment of asthmaN Engl J Med2010362131169117120181964
  • ThomasMKaySPikeJThe asthma control test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional surveyPrim Care Respir J2009181414919240948
  • SaitoJGibeonDMacedoPMenzies-GowABhavsarPKChungKFDomiciliary diurnal variation of exhaled nitric oxide fraction for asthma controlEur Respir J201443247448423949962
  • GodardPGreillierPPigeariasBNachbaurGDesfougeresJLAttaliVMaintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double blind randomised studyRespir Med200810281124113118606533
  • BrozekJLKraftMKrishnanJALong-acting β2-agonist step-off in patients with controlled asthmaArch Intern Med2012172181365137522928176
  • WellsKEPetersonELAhmedaniBKSeversonRKGleason-ComstockJWilliamsLKThe relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse populationJ Allergy Clin Immunol201212951274127922281166
  • PedersenSO’ByrnePMCombination inhaled corticosteroid and long-acting β2-agonist use and severe asthma exacerbationsJ Allegy Clin Immunol2012129512801281
  • SalpeterSRWallAJBuckleyNSLong-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma eventsAm J Med2010123432232820176343
  • AdachiMAizawaHIshiharaKComparison of salmeterol/fluticasone propionate (FP) combination with FP + sustained release theophylline in moderate asthma patientsRespir Med200810271055106418394875
  • KetaiLHarkinsMFiatoKLIwamotoGKExhaled nitric oxide and bronchial wall thickening in asthmatics during and after acute exacerbation: evidence of bronchial wall remodelingJ Asthma200542866767116266958
  • GraingeCLLauLCWardJAEffect of bronchoconstriction on airway remodeling in asthmaN Eng J Med20113642120062015